JZHG Financials Monday, July 14, 2014 12:03:15 PM

JZHG Financials Monday, July 14, 2014 12:03:15 PM
JinZangHuang Tibet Pharmaceuticals, Inc.
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 10,653 3,717 642
Cost of Revenue 2,219 720 464
Gross Profit 8,434 2,996 178
Operating Expenses
Research and Development - - -
Sales, General and Admin. 354 143 238
Non-Recurring Items - 288 -
Other - - -
Operating Income 8,080 2,565 (59)
Income From Continuing Operations
Add'l Income/Expense Items 21 2 -
Earnings Before Interest and Tax 8,100 2,567 (59)
Interest Expense - - -
Earnings Before Tax 8,100 2,567 (59)
Income Tax 1,947 701 9
Minority Interest 304 94 -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 5,850 1,772 (68)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 5,850 1,772 (68)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 5,850 1,772 (68)